Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes - Takeaways - MDSpire
From the Journals

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation

Share

  • 1

    Study involved 1,006 patients with atrial fibrillation.

  • 2

    Focus on outcomes after ischemic strokes during DOAC therapy.

  • 3

    Primary outcome: recurrent stroke and bleeding.

  • 4

    54% switched therapy; no short-term benefit found.

  • 5

    Noninferiority not established for mortality.

  • 6

    Generalizability limited to high-volume centers.

  • 7

    Important for decision-making in anticoagulant therapy.

  • 8

    Consider adherence and interactions before switching.

Original Source(s)

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

  • by Andrea Surnit

  • April 30, 2026

Related Content

Cognition-Affecting Drugs Often Start in Acute Care

Older patients frequently continued these medication classes 1 year after initiation

Model May Reframe Tension-Type Headache

Proposed framework organizes interacting factors into four domains to guide personalized assessment

FDA Approves Auvelity for Agitation in Alzheimer’s Disease

The oral combination therapy expands treatment options for agitation associated with dementia due to Alzheimer’s disease.